Home1541 • HKG
add
ImmuneOnco Biopharmaceuticls Shanghi Inc
Nakaraang pagsara
$6.63
Sakop ng araw
$5.93 - $6.66
Sakop ng taon
$3.21 - $22.00
Market cap
2.46B HKD
Average na Volume
3.58M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 39.41M | 1,099.47% |
Gastos sa pagpapatakbo | 119.19M | 17.41% |
Net na kita | -75.05M | 28.06% |
Net profit margin | -190.43 | 94.00% |
Kita sa bawat share | — | — |
EBITDA | -77.53M | 18.50% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 752.12M | 23.59% |
Kabuuang asset | 922.00M | 5.42% |
Kabuuang sagutin | 243.69M | 92.94% |
Kabuuang equity | 678.30M | — |
Natitirang share | 407.31M | — |
Presyo para makapag-book | 3.97 | — |
Return on assets | -21.63% | — |
Return on capital | -24.48% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -75.05M | 28.06% |
Cash mula sa mga operasyon | -2.51M | 97.87% |
Cash mula sa pag-invest | -1.16M | 99.10% |
Cash mula sa financing | 118.71M | -22.26% |
Net change in cash | 115.38M | 222.10% |
Malayang cash flow | -39.46M | 5.33% |
Tungkol
Itinatag
2015
Website
Mga Empleyado
156
